Antimicrobial Activity of Glycyrrhizinic Acid Is pH-Dependent by Mathieu Joos (20331128)

“…The antimicrobial activity of the hydrogel cannot solely be attributed to the resulting pH decrease of the suspension, as the presence of GA significantly increases the activity. …”

5-HT- induced mitochondrial ROS inhibits <i>P</i>. <i>berghei</i> infection. by Li Gao (131516)

Subjects:

DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx by Teresa Fontán-Baselga (20392470)

“…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …”

Study selection criteria. by Filip Stanicic (17808254)

“…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …”

PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …”

PRISMA flow chart. by Filip Stanicic (17808254)

“…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …”

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Time course of Path Length, LFS and Velocity during postural training. by Cristina Dolciotti (16317330)

Training-induced changes in bipedal stance. by Cristina Dolciotti (16317330)

Time course of 95% Area, X and Y Amplitude Sway during postural training. by Cristina Dolciotti (16317330)

Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training. by Cristina Dolciotti (16317330)